EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H31FN7O6P |
| Net Charge | 0 |
| Average Mass | 587.549 |
| Monoisotopic Mass | 587.20575 |
| SMILES | CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)nn3)ncnc2c1)CCOP(=O)(O)O |
| InChI | InChI=1S/C26H31FN7O6P/c1-2-34(10-12-40-41(36,37)38)9-4-11-39-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(35)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17H,2,4,9-12,15H2,1H3,(H,30,35)(H2,36,37,38)(H2,28,29,31,32,33) |
| InChIKey | GBJVVSCPOBPEIT-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | Aurora kinase inhibitor Any protein kinase inhibitor that inhibits the action of an Aurora kinase (a group of serine/threonine kinases that are essential for cell proliferation). |
| Applications: | prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| AZT-1152 (CHEBI:167636) has functional parent AZD-1152 (CHEBI:91367) |
| AZT-1152 (CHEBI:167636) has role antineoplastic agent (CHEBI:35610) |
| AZT-1152 (CHEBI:167636) has role Aurora kinase inhibitor (CHEBI:70770) |
| AZT-1152 (CHEBI:167636) has role prodrug (CHEBI:50266) |
| AZT-1152 (CHEBI:167636) is a anilide (CHEBI:13248) |
| AZT-1152 (CHEBI:167636) is a monoalkyl phosphate (CHEBI:25381) |
| AZT-1152 (CHEBI:167636) is a monofluorobenzenes (CHEBI:83575) |
| AZT-1152 (CHEBI:167636) is a pyrazoles (CHEBI:26410) |
| AZT-1152 (CHEBI:167636) is a quinazolines (CHEBI:38530) |
| AZT-1152 (CHEBI:167636) is a secondary amino compound (CHEBI:50995) |
| AZT-1152 (CHEBI:167636) is a secondary carboxamide (CHEBI:140325) |
| AZT-1152 (CHEBI:167636) is a tertiary amino compound (CHEBI:50996) |
| IUPAC Name |
|---|
| 2-[ethyl(3-{[4-({5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl}amino)quinazolin-7-yl]oxy}propyl)amino]ethyl dihydrogen phosphate |
| INNs | Source |
|---|---|
| barasertib | ChEBI |
| barasertib | ChEBI |
| barasertibum | ChEBI |
| barasertib | ChEBI |
| Synonyms | Source |
|---|---|
| AZD1152-HQPA dihydrogen phosphate | ChEBI |
| AZD2811 | ChEBI |
| INH-34 | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| DB11747 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| CAS:722543-31-9 | ChemIDplus |
| CAS:957881-03-7 | ChemIDplus |
| Citations |
|---|